Table 2.
Bivariate correlations between accelerometer assessed sedentary behaviour patterns, light physical activity and MVPA with 10-year CVD risk, individual CVD risk factors and functional disability
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | 19 | 20 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | Age | ||||||||||||||||||||
2 | Sedentary time (min/day) | .29* | |||||||||||||||||||
3 | bLPA (min/day) | −.22 | −.78** | ||||||||||||||||||
4 | bMVPA (min/day) | −.22 | −.37** | .35** | |||||||||||||||||
5 | Number of Sbreaks (number/day) | −.12 | −.26* | .61** | .03 | ||||||||||||||||
6 | Number of Sbouts (number/day) | .31* | .81* | −.79** | −.26** | −.67** | |||||||||||||||
7 | Average time per Sbout (min) | .07 | .34** | −.50** | −.09 | −.56** | .45** | ||||||||||||||
8 | Q-risk | .76** | .37** | −.40** | −.12 | −.21 | .38** | .20 | |||||||||||||
9 | bCRP (mg/L) | .18 | .05 | −.20 | −.24 | −.20 | .15 | .09 | .28* | ||||||||||||
10 | bESR (mm/h) | .12 | .20 | −.23 | −.21 | −.09 | .21 | −.01 | .17 | .57** | |||||||||||
11 | Fibrinogen (g/L) | .25 | .20 | −.27* | −.23 | −.19 | .31* | .03 | .29* | .69** | .71** | ||||||||||
12 | Total cholesterol (mmol/L) | .18 | .17 | −.10 | −.18 | .04 | .03 | .11 | .09 | .10 | .14 | − .03 | |||||||||
13 | bHDL-C (mmol/L) | .05 | −.11 | .27* | .02 | .30* | −.25† | −.17 | −.33* | −.20 | −.10 | −.24 | .29* | ||||||||
14 | bLDL-C (mmol/L) | .15 | .22 | −.19 | −.14 | −.13 | .15 | .19 | .19 | .22 | .19 | .06 | .86** | −.09 | |||||||
15 | bTriglycerides (mmol/L) | .10 | .13 | −.19 | −.17 | −.02 | .08 | .17 | .22 | −.00 | .14 | .11 | .33* | −.24b | .13 | ||||||
16 | Syst-BP (mm HG) | .53** | .19 | −.09 | −.04 | .05 | .17 | .04 | .52** | .16 | .19 | .17 | .11 | .28* | −.11 | .22 | |||||
17 | Diast-BP (mm HG) | .37* | .08 | .15 | .02 | .11 | .13 | .01 | .30* | −.05 | −.03 | −.01 | .12 | .23 | −.07 | .22 | .71** | ||||
18 | bPlasma insulin (mmol/L) | −.08 | .05 | −.11 | −.21 | −.08 | .13 | −.08 | .16 | .28* | .35* | .37* | −.03 | −.47** | .08 | .37** | .10 | .14 | |||
19 | bPlasma glucose (mmol/L) | .02 | .04 | −.04 | .06 | .05 | .01 | .11 | .12 | .06 | .13 | .10 | .07 | −.30* | .12 | .27* | .10 | .19 | .51** | ||
20 | bHOMA status | −.08 | .06 | −.09 | −.17 | −.02 | .09 | −.01 | .16 | .23 | .30* | .31* | −.04 | −.47** | .05 | .35** | .06 | .12 | .94** | .74** | |
21 | HAQ | .09 | .13 | −.23 | −.27* | −.16 | .17 | .06 | .13 | .18 | .27** | .23 | −.04 | −.03 | .03 | −.11 | .07 | .02 | .26** | − .04 | .18 |
Note: * p < .05, ** p < .01, † p = .05, a p = .06. b Indicates non-normally distributed data that has been log transformed for inclusion parametric statistical tests
LPA light physical activity, MVPA moderate-to-vigorous physical activity, Sbreaks sedentary breaks, Sbouts sedentary bouts, CVD cardiovascular disease, HOMA homeostatic model assessment, HDL-C high-density lipoprotein cholesterol, LDL-C low-density lipoprotein cholesterol, CRP C-reactive protein, ESR erythrocyte sedimentation rate, Qrisk Q-risk score, HAQ Health Assessment Questionnaire